2025-04-012026-03-312026-03-31false10663153SMT ORTHOPAEDICS LTD2026-10-02falseiso4217:GBPxbrli:pure106631532025-03-31106631532026-03-31106631532025-04-012026-03-31106631532024-03-31106631532025-03-31106631532024-04-012025-03-3110663153bus:SmallEntities2025-04-012026-03-3110663153bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3110663153bus:FullAccounts2025-04-012026-03-3110663153bus:PrivateLimitedCompanyLtd2025-04-012026-03-3110663153core:WithinOneYear2026-03-3110663153core:AfterOneYear2026-03-3110663153core:WithinOneYear2025-03-3110663153core:AfterOneYear2025-03-3110663153core:ShareCapital2026-03-3110663153core:SharePremium2026-03-3110663153core:RevaluationReserve2026-03-3110663153core:OtherReservesSubtotal2026-03-3110663153core:RetainedEarningsAccumulatedLosses2026-03-3110663153core:ShareCapital2025-03-3110663153core:SharePremium2025-03-3110663153core:RevaluationReserve2025-03-3110663153core:OtherReservesSubtotal2025-03-3110663153core:RetainedEarningsAccumulatedLosses2025-03-3110663153core:LandBuildings2026-03-3110663153core:PlantMachinery2026-03-3110663153core:Vehicles2026-03-3110663153core:FurnitureFittings2026-03-3110663153core:OfficeEquipment2026-03-3110663153core:NetGoodwill2026-03-3110663153core:IntangibleAssetsOtherThanGoodwill2026-03-3110663153core:ListedExchangeTraded2026-03-3110663153core:UnlistedNon-exchangeTraded2026-03-3110663153core:LandBuildings2025-03-3110663153core:PlantMachinery2025-03-3110663153core:Vehicles2025-03-3110663153core:FurnitureFittings2025-03-3110663153core:OfficeEquipment2025-03-3110663153core:NetGoodwill2025-03-3110663153core:IntangibleAssetsOtherThanGoodwill2025-03-3110663153core:ListedExchangeTraded2025-03-3110663153core:UnlistedNon-exchangeTraded2025-03-3110663153core:LandBuildings2025-04-012026-03-3110663153core:PlantMachinery2025-04-012026-03-3110663153core:Vehicles2025-04-012026-03-3110663153core:FurnitureFittings2025-04-012026-03-3110663153core:OfficeEquipment2025-04-012026-03-3110663153core:NetGoodwill2025-04-012026-03-3110663153core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110663153core:ListedExchangeTraded2025-04-012026-03-3110663153core:UnlistedNon-exchangeTraded2025-04-012026-03-3110663153core:MoreThanFiveYears2025-04-012026-03-3110663153core:Non-currentFinancialInstruments2026-03-3110663153core:Non-currentFinancialInstruments2025-03-3110663153dpl:CostSales2025-04-012026-03-3110663153dpl:DistributionCosts2025-04-012026-03-3110663153core:LandBuildings2025-04-012026-03-3110663153core:PlantMachinery2025-04-012026-03-3110663153core:Vehicles2025-04-012026-03-3110663153core:FurnitureFittings2025-04-012026-03-3110663153core:OfficeEquipment2025-04-012026-03-3110663153dpl:AdministrativeExpenses2025-04-012026-03-3110663153core:NetGoodwill2025-04-012026-03-3110663153core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110663153dpl:GroupUndertakings2025-04-012026-03-3110663153dpl:ParticipatingInterests2025-04-012026-03-3110663153dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3110663153core:ListedExchangeTraded2025-04-012026-03-3110663153dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3110663153core:UnlistedNon-exchangeTraded2025-04-012026-03-3110663153dpl:CostSales2024-04-012025-03-3110663153dpl:DistributionCosts2024-04-012025-03-3110663153core:LandBuildings2024-04-012025-03-3110663153core:PlantMachinery2024-04-012025-03-3110663153core:Vehicles2024-04-012025-03-3110663153core:FurnitureFittings2024-04-012025-03-3110663153core:OfficeEquipment2024-04-012025-03-3110663153dpl:AdministrativeExpenses2024-04-012025-03-3110663153core:NetGoodwill2024-04-012025-03-3110663153core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110663153dpl:GroupUndertakings2024-04-012025-03-3110663153dpl:ParticipatingInterests2024-04-012025-03-3110663153dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110663153core:ListedExchangeTraded2024-04-012025-03-3110663153dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110663153core:UnlistedNon-exchangeTraded2024-04-012025-03-3110663153core:NetGoodwill2026-03-3110663153core:IntangibleAssetsOtherThanGoodwill2026-03-3110663153core:LandBuildings2026-03-3110663153core:PlantMachinery2026-03-3110663153core:Vehicles2026-03-3110663153core:FurnitureFittings2026-03-3110663153core:OfficeEquipment2026-03-3110663153core:AfterOneYear2026-03-3110663153core:WithinOneYear2026-03-3110663153core:ListedExchangeTraded2026-03-3110663153core:UnlistedNon-exchangeTraded2026-03-3110663153core:ShareCapital2026-03-3110663153core:SharePremium2026-03-3110663153core:RevaluationReserve2026-03-3110663153core:OtherReservesSubtotal2026-03-3110663153core:RetainedEarningsAccumulatedLosses2026-03-3110663153core:NetGoodwill2025-03-3110663153core:IntangibleAssetsOtherThanGoodwill2025-03-3110663153core:LandBuildings2025-03-3110663153core:PlantMachinery2025-03-3110663153core:Vehicles2025-03-3110663153core:FurnitureFittings2025-03-3110663153core:OfficeEquipment2025-03-3110663153core:AfterOneYear2025-03-3110663153core:WithinOneYear2025-03-3110663153core:ListedExchangeTraded2025-03-3110663153core:UnlistedNon-exchangeTraded2025-03-3110663153core:ShareCapital2025-03-3110663153core:SharePremium2025-03-3110663153core:RevaluationReserve2025-03-3110663153core:OtherReservesSubtotal2025-03-3110663153core:RetainedEarningsAccumulatedLosses2025-03-3110663153core:NetGoodwill2024-03-3110663153core:IntangibleAssetsOtherThanGoodwill2024-03-3110663153core:LandBuildings2024-03-3110663153core:PlantMachinery2024-03-3110663153core:Vehicles2024-03-3110663153core:FurnitureFittings2024-03-3110663153core:OfficeEquipment2024-03-3110663153core:AfterOneYear2024-03-3110663153core:WithinOneYear2024-03-3110663153core:ListedExchangeTraded2024-03-3110663153core:UnlistedNon-exchangeTraded2024-03-3110663153core:ShareCapital2024-03-3110663153core:SharePremium2024-03-3110663153core:RevaluationReserve2024-03-3110663153core:OtherReservesSubtotal2024-03-3110663153core:RetainedEarningsAccumulatedLosses2024-03-3110663153core:AfterOneYear2025-04-012026-03-3110663153core:WithinOneYear2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110663153core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3110663153core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3110663153core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110663153core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110663153core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110663153core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110663153core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110663153core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110663153core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110663153core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110663153core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110663153bus:Director12025-04-012026-03-3110663153bus:Director22025-04-012026-03-3110663153core:FurnitureFittingsToolsEquipment2025-03-3110663153core:FurnitureFittingsToolsEquipment2025-04-012026-03-3110663153core:FurnitureFittingsToolsEquipment2026-03-31

SMT ORTHOPAEDICS LTD

Registered Number
10663153
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

SMT ORTHOPAEDICS LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

TAI, Sabina Mary
TAI, Stephen Michael Mason

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

10663153 (England and Wales)
SMT ORTHOPAEDICS LTD
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets3224,8791,447
224,8791,447
Current assets
Debtors4273,92639,440
Current asset investments594,66042,000
Cash at bank and on hand339,755543,455
708,341624,895
Creditors amounts falling due within one year6(350,190)(171,782)
Net current assets (liabilities)358,151453,113
Total assets less current liabilities583,030454,560
Net assets583,030454,560
Capital and reserves
Called up share capital150150
Profit and loss account582,880454,410
Shareholders' funds583,030454,560
The financial statements were approved and authorised for issue by the Board of Directors on 2 October 2026, and are signed on its behalf by:
TAI, Stephen Michael Mason
Director
Registered Company No. 10663153
SMT ORTHOPAEDICS LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
The trading results of the overseas branch are translated into sterling at the average economic rate for the financial year, while the assets & liabilities are recorded at the closing rates and any resulting translation differences are recognised directly in equity.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20262025
Average number of employees during the year22
3.Tangible fixed assets

Land & buildings

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 25-1,0736,7267,799
Additions219,0033,4742,316224,793
At 31 March 26219,0034,5479,042232,592
Depreciation and impairment
At 01 April 25-8895,4636,352
Charge for year-2111,1501,361
At 31 March 26-1,1006,6137,713
Net book value
At 31 March 26219,0033,4472,429224,879
At 31 March 25-1841,2631,447
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables272,47438,840
Other debtors54-
Prepayments and accrued income1,398600
Total273,92639,440
5.Current asset investments
The company holds an unlisted investment in Wesleyan, valued in accordance with the company’s accounting policies for such investments.
6.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables234,6971,262
Taxation and social security98,087106,070
Other creditors10,20658,527
Accrued liabilities and deferred income7,2005,923
Total350,190171,782